हिंदी में पढ़ें

Aurobindo Pharma

Aurobindo Pharma unit gets first product approval from USFDA

Aurobindo Pharma unit gets first product approval from USFDA

Wed, Sep 11, 2024

The new injectable facility of Eugia Steriles, a subsidiary of Eugia Pharma Specialities and a stepdown unit of the company, situated at Anakapalli District of Andhra Pradesh was inspected by the US FDA from March 28 to April 5 this year.

Aurobindo Pharma arm gets warning letter from USFDA for formulations unit in Telangana

Aurobindo Pharma arm gets warning letter from USFDA for formulations unit in Telangana

Fri, Aug 16, 2024

Aurobindo Pharma Ltd's subsidiary Eugia Pharma Specialities Ltd has received a warning letter from the USFDA for its Telangana-based formulation manufacturing unit. This follows the unit's earlier classification as 'Official Action Indicated' (OAI). Despite this, the company assures there is no impact on current US market supplies and remains committed to improving compliance with FDA regulations.

Analyzing Aurobindo Pharma's Recent Action

Analyzing Aurobindo Pharma's Recent Action

Mon, Jul 15, 2024

Why is Aurobindo Pharma in action? Board meeting on July 18, big decision possible. Know complete details from Nupur.

TRENDING NOW

Cipla share price plunges nearly 6 pct after USFDA issues warning letter for Goa facility

Cipla share price plunges nearly 6 pct after USFDA issues warning letter for Goa facility

Wed, Feb 26, 2020

Cipla tumbled nearly 6 per cent after the US health regulator issued a warning letter for its Goa manufacturing facility.

Sensex, Nifty rise ahead of US-China trade deal; NALCO, Hero MotoCorp, Aurobindo Pharma stocks gain

Sensex, Nifty rise ahead of US-China trade deal; NALCO, Hero MotoCorp, Aurobindo Pharma stocks gain

Tue, Jan 14, 2020

The stock market of Indian trade range-bound ahead of the much-awaited US-China trade deal scheduled on 15th January 2020. The BSE Sensex rose 92 points and closed at 41,952 levels while the 50-stocks Nifty went up 32 points and closed at 12,362 levels.

Sensex, Nifty slip on sixth straight trade session; Aurobindo Pharma, DHFL, Ashok Leyland stocks bleed

Sensex, Nifty slip on sixth straight trade session; Aurobindo Pharma, DHFL, Ashok Leyland stocks bleed

Mon, Oct 07, 2019

The stock market of India sinks on sixth straight trade session. The BSE Sensex lost 141 points and closed at 37,531 levels while the 50-stock Nifty went down 48 points and closed at 11,126 level after the closing bell trade session.

Sensex soars over 600 points, Nifty climbs 11K, Bank Nifty scales 28K; Aurobindo Pharma, Vodafone Idea stocks gain

Sensex soars over 600 points, Nifty climbs 11K, Bank Nifty scales 28K; Aurobindo Pharma, Vodafone Idea stocks gain

Thu, Aug 08, 2019

The BSE Sensex shot up 636 points and closed at 37,327 levels while the Nifty-50 index scaled 11,000 levels after gaining 176 points today. The Bank Nifty index shot up 408 points and closed above 28,00 levels at 28,110 levels.

Sensex, Nifty find comfort in Chinese trade data, yuan fix; Aurobindo Pharma, Yes Bank stocks gain

Sensex, Nifty find comfort in Chinese trade data, yuan fix; Aurobindo Pharma, Yes Bank stocks gain

Thu, Aug 08, 2019

The BSE Sensex opened 175 point sup at 36,866 levels while the 50-stock Nifty opened 58 points higher at 10,913 levels. the Bank Nifty index was 117 points up at 27,819 levels.

Stocks in Focus on July 11: Infra stocks, DHFL to Ajmera Realty; here are the 5 Newsmakers of the Day

Stocks in Focus on July 11: Infra stocks, DHFL to Ajmera Realty; here are the 5 Newsmakers of the Day

Thu, Jul 11, 2019

There are certain stocks that came in news after the market was closed on Wednesday and can play a pivotal role on Thursday intraday trade.

Aurobindo Pharma completes $300 mn deal to acquire 7 oncology products from US-based firm.

Aurobindo Pharma completes $300 mn deal to acquire 7 oncology products from US-based firm.

Sat, Mar 02, 2019

According to the definitive agreements inked between the two companies, Acrotech Biopharma LLC, a subsidiary of Aurobindo, will pay an upfront purchase price of USD 160 million in cash plus up to USD 140 million on achieving regulatory and sales-based milestones for the seven products.

Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018

Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018

Mon, Dec 31, 2018

The sector has been volatile throughout the year due to constant news flow in the markets. Some giants of the sector witnessed objections over their manufacturing plants and medicine pricing in the U.S. markets.

Aurobindo Pharma touches all-time high, soars by 9% on Sandoz deal

Aurobindo Pharma touches all-time high, soars by 9% on Sandoz deal

Fri, Sep 07, 2018

With the blockbaster performance of today Aurobindo Pharma has now given a performance of 56.78% in a year.

Aurobindo Pharma acquires Apotex Inc for 74 mn euros

Aurobindo Pharma acquires Apotex Inc for 74 mn euros

Sun, Jul 15, 2018

Transaction will be made wholly in cash, for which Aurobindo will pay about 74 million euros (which is approx Rs 5 billion). The company will not assume any debt as part of this transaction.

Aurobindo Pharma plant inspection: FDA team finds 'female mosquito' in its facility

Aurobindo Pharma plant inspection: FDA team finds 'female mosquito' in its facility

Sun, Mar 11, 2018

Aurobindo Pharma facility inspection: The US FDA had issued nine observations after inspection of the drug maker's Unit 4 formulation facility near Hyderabad last month

FAST MONEY: Saksoft, Aurobindo Pharma among 10 buy and sell calls for today's trade

FAST MONEY: Saksoft, Aurobindo Pharma among 10 buy and sell calls for today's trade

Thu, Feb 22, 2018

The domestic market is expected to open lower, tracking Asian markets, which slipped on Thursday as the risk of faster hikes in US interest rates lifted short-term Treasury yields to the highest in almost a decade and boosted the dollar.

Goldman Sachs picks four Indian companies for its Asia Stock Collection; look how they performed in one year

Goldman Sachs picks four Indian companies for its Asia Stock Collection; look how they performed in one year

Wed, Jun 21, 2017

"Asia is the home of Active. From Alibaba to Yili, Alps to Maruti, we go back to first principles on our differentiated, liquid and idiosyncratic stock ideas in Asia", Goldman Sachs said in Asia Stock Collection report.

Aurobindo Pharma eyes US plant amid Trump push on jobs

Aurobindo Pharma eyes US plant amid Trump push on jobs

Fri, Feb 10, 2017

India`s drug industry is worth about $15 billion and supplies roughly 30 percent of the medicines sold in the United States.

BSE, telecom shares open flat; Aurobindo Pharma drops

BSE, telecom shares open flat; Aurobindo Pharma drops

Fri, Oct 07, 2016

Shares of telecom companies like Bharti Airtel, Reliance Communications, Idea Cellular remained unresponsive after spectrum auction ended on Thursday.

Pharma likely to see double-digit revenue growth in first quarter

Pharma likely to see double-digit revenue growth in first quarter

Tue, Jul 12, 2016

Surya Patra and Mehul Sheth of Phillip Capital said, in Q1FY17, pharma industry to see top-line and bottom-line growth by 16% and 24% respectively, primarily due to robust performance from Sun Pharma, led by its product gGleevec.

Antim Bazi : Experts outlook and advise for trade in Indian Market

Antim Bazi : Experts outlook and advise for trade in Indian Market

Tue, Jul 05, 2016

Watch this special segment and get to know more here.

Brexit impact: Indian pharma seems immune, says Phillip Capital

Brexit impact: Indian pharma seems immune, says Phillip Capital

Mon, Jun 27, 2016

"Brexit has raised business concerns around the world about trade and currency fluctuations, but Indian pharma seems immune," Surya Patra and Mehul Sheth from Phillip Capital Research said in research note on June 24.

WATCH: Top 7 corporate news this afternoon; From Andhra Bank receiving board's nod to Apollo Hospitals partnering with Chinese company

WATCH: Top 7 corporate news this afternoon; From Andhra Bank receiving board's nod to Apollo Hospitals partnering with Chinese company

Tue, Jun 21, 2016

Zee Business brings you the most important stories of the day that will help you shape your market strategies and keep you informed with the latest developments. Today's top seven corporate news: 1. Andhra Bank's board okays raising Rs 1,000 crore via bonds

Aurobindo Pharma reports 40% rise in Q4; stocks up 4%

Aurobindo Pharma reports 40% rise in Q4; stocks up 4%

Tue, May 31, 2016

The company's net profit for the January-March quarter rose to Rs 5.63 billion ($83.9 million) from Rs 4.03 billion a year earlier, Aurobindo said in a statement late on Monday.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x